The University of Chicago Header Logo

Connection

Evgeny Izumchenko to CTLA-4 Antigen

This is a "connection" page, showing publications Evgeny Izumchenko has written about CTLA-4 Antigen.
Connection Strength

0.037
  1. Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFß enhance the efficacy of cancer immunotherapy. Nat Commun. 2018 02 21; 9(1):741.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.